Ventripoint Diagnostics Ltd.

DB:5V7 Stock Report

Market Cap: €14.8m

Ventripoint Diagnostics Past Earnings Performance

Past criteria checks 0/6

Ventripoint Diagnostics's earnings have been declining at an average annual rate of -15.1%, while the Medical Equipment industry saw earnings declining at 1.1% annually. Revenues have been declining at an average rate of 4.2% per year.

Key information

-15.1%

Earnings growth rate

10.7%

EPS growth rate

Medical Equipment Industry Growth4.3%
Revenue growth rate-4.2%
Return on equityn/a
Net Margin-6,966.1%
Last Earnings Update30 Jun 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Ventripoint Diagnostics makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

DB:5V7 Revenue, expenses and earnings (CAD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 240-541
31 Mar 240-541
31 Dec 230-541
30 Sep 230-541
30 Jun 230-541
31 Mar 230-541
31 Dec 220-541
30 Sep 220-541
30 Jun 220-441
31 Mar 220-330
31 Dec 210-430
30 Sep 210-330
30 Jun 210-330
31 Mar 210-220
31 Dec 200-220
30 Sep 200-220
30 Jun 200-221
31 Mar 200-321
31 Dec 190-321
30 Sep 190-421
30 Jun 190-321
31 Mar 190-331
31 Dec 180-221
30 Sep 180-321
30 Jun 180-331
31 Mar 180021
31 Dec 170-421
30 Sep 170-221
30 Jun 170-311
31 Mar 170-611
31 Dec 160-311
30 Sep 160-211
30 Jun 160-211
31 Mar 160-211
31 Dec 150-211
30 Sep 150-210
30 Jun 150-220
31 Mar 150-221
31 Dec 140-211
30 Sep 140-111
30 Jun 140-211
31 Mar 140-211
31 Dec 130-222

Quality Earnings: 5V7 is currently unprofitable.

Growing Profit Margin: 5V7 is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 5V7 is unprofitable, and losses have increased over the past 5 years at a rate of 15.1% per year.

Accelerating Growth: Unable to compare 5V7's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 5V7 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (10.1%).


Return on Equity

High ROE: 5V7's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.


Return on Assets


Return on Capital Employed


Discover strong past performing companies